Research ArticleCystic Fibrosis

Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis

Science Translational Medicine  23 Jul 2014:
Vol. 6, Issue 246, pp. 246ra96
DOI: 10.1126/scitranslmed.3008680

You are currently viewing the pdf extract.

View Full Text
As a service to the community, AAAS/Science has made this article free with registration.

You do not have access to the full text of this article, the first page of the PDF of this article appears below.

PDF extract preview